Basilea Pharmaceutica AG: Basilea presents preclinical data

Basel, Switzerland, October 11, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today the presentation of data from preclinical studies demonstrating synergistic anti-tumor effects in a number

Related Keywords

Japan , Basilea , Basel Stadt , Switzerland , United States , Kenilworth , Warwickshire , United Kingdom , America , British , Swiss , Nils Schr , Laurenz Kellenberger , Head Of Corporate Communications Investor Relations , Arqule Inc , Swiss Exchange , Basilea Pharmaceutica Ltd , Virtual International Conference On Molecular , Cancer Research , Merck Co Inc , Clinical Cancer Research , Virtual International Conference , Molecular Targets , Cancer Therapeutics , Colony Stimulating Factor , Chief Scientific Officer , Basilea Pharmaceutica , Corporate Communications , Investor Relations , Oncology Reports , World Journal , National Academy , Pharmaceutica , Presents , Reclinical , Data , Synergy , Between , Derazantinib , Paclitaxel , Pastric , Humor , Models , Conference ,